Hyderabad Telangana, India

Rajkumar Bhimrao Shinde

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajkumar Bhimrao Shinde. Retrieved from https://idiyas.com/inventor/rajkumar-bhimrao-shinde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajkumar Bhimrao Shinde: Innovator in Pharmaceutical Compositions

Introduction

Rajkumar Bhimrao Shinde is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent that addresses important medical needs.

Latest Patents

Shinde holds a patent for "Pharmaceutical compositions comprising boronic acid compounds." This pharmaceutical composition includes bortezomib or its pharmaceutically acceptable salt or solvate, tromethamine, and an organic carboxylic acid. The pH of this composition is maintained between about 3.0 to 6.0, which is crucial for its effectiveness.

Career Highlights

Rajkumar Shinde is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in healthcare. His work at Dr. Reddy's has allowed him to focus on developing advanced pharmaceutical solutions that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Navin Vaya and Harshal Prabhakar Bhagwatwar, who have collaborated with him on various projects within the pharmaceutical domain.

Conclusion

Rajkumar Bhimrao Shinde's contributions to pharmaceutical compositions highlight his role as an innovator in the industry. His patent reflects a commitment to advancing medical science and improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…